secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiniMed Group, Inc. (MMED)
CIK:        0002062583
Form:       8-K
Filed at:   2026-09-01T10:50:10+00:00
Accession:  0001628280-26-059699
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiniMed Q1 FY27 net sales $843M +16.6%; raises FY27 organic growth to ~10.5%
----------------------------------------------------------------------------

- Net sales $843M, +16.6% as reported, +15.8% organic; U.S. +13.1% to $240M, international +18.1% to $603M.
- Worldwide NPS ~34,000 (+7.7% YoY); CGM attachment rate 69% (+~100bps QoQ).
- Raises FY27 organic revenue growth to ~10.5% (from ~10%); reaffirms adjusted EBITDA margin ~16%.
- Pipeline: MiniMed Fit FDA submission ahead of Fall; Flex CE Mark; Vivera pivotal enrollment complete; next-gen sensor IDE approved.
- U.S. launch of MiniMed Flex with Instinct started Aug 17; Medicare coverage expanded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/0001628280-26-059699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/mmed-20260901.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-059699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer